X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2856) 2856
Publication (167) 167
Book Review (68) 68
Book Chapter (46) 46
Magazine Article (5) 5
Book / eBook (2) 2
Conference Proceeding (2) 2
Dissertation (2) 2
Newsletter (2) 2
Transcript (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1594) 1594
humans (1486) 1486
direct oral anticoagulants (1111) 1111
anticoagulants (1004) 1004
warfarin (938) 938
dabigatran (860) 860
rivaroxaban (776) 776
direct thrombin inhibitor (771) 771
venous thromboembolism (732) 732
atrial fibrillation (696) 696
hematology (661) 661
anticoagulants - therapeutic use (590) 590
administration, oral (566) 566
peripheral vascular disease (541) 541
male (487) 487
apixaban (464) 464
female (430) 430
dabigatran etexilate (427) 427
atrial-fibrillation (426) 426
stroke (425) 425
anticoagulants - administration & dosage (416) 416
anticoagulants - adverse effects (408) 408
thromboembolism (407) 407
pharmacology & pharmacy (402) 402
cardiac & cardiovascular systems (394) 394
prevention (372) 372
aged (355) 355
anticoagulation (328) 328
thrombin (327) 327
thrombosis (310) 310
middle aged (281) 281
risk factors (275) 275
pharmacokinetics (273) 273
bleeding (271) 271
atrial fibrillation - drug therapy (264) 264
direct oral anticoagulant (264) 264
hemorrhage - chemically induced (259) 259
management (258) 258
safety (253) 253
medicine & public health (251) 251
treatment outcome (250) 250
molecular-weight heparin (246) 246
medicine, general & internal (244) 244
direct thrombin inhibitors (243) 243
stroke prevention (240) 240
blood coagulation - drug effects (231) 231
analysis (230) 230
factor xa inhibitors (229) 229
stroke - prevention & control (221) 221
therapy (219) 219
factor xa inhibitor (218) 218
surgery (218) 218
risk (213) 213
anticoagulants - pharmacology (211) 211
factor-xa inhibitor (210) 210
deep-vein thrombosis (209) 209
antithrombotic therapy (208) 208
oral anticoagulants (199) 199
patients (199) 199
pharmacodynamics (198) 198
adult (197) 197
care and treatment (194) 194
heparin (194) 194
atrial fibrillation - complications (188) 188
edoxaban (188) 188
aged, 80 and over (182) 182
cardiology (177) 177
animals (176) 176
double-blind (175) 175
nonvalvular atrial-fibrillation (175) 175
drug therapy (172) 172
prothrombin complex concentrate (168) 168
hemorrhage (162) 162
thrombin - antagonists & inhibitors (154) 154
cardiac arrhythmia (149) 149
internal medicine (149) 149
ximelagatran (146) 146
abridged index medicus (144) 144
enoxaparin (143) 143
beta-alanine - analogs & derivatives (142) 142
clinical trials (140) 140
health aspects (140) 140
anticoagulants - pharmacokinetics (136) 136
vitamin k - antagonists & inhibitors (136) 136
pulmonary embolism (133) 133
warfarin - therapeutic use (131) 131
coagulation (130) 130
reversal (130) 130
medical research (128) 128
venous thromboembolism - drug therapy (128) 128
vitamin k antagonists (128) 128
thromboembolism - prevention & control (127) 127
stroke - etiology (125) 125
review (123) 123
dosage and administration (122) 122
efficacy (122) 122
mortality (122) 122
benzimidazoles - therapeutic use (119) 119
coagulation assays (118) 118
medicine, experimental (118) 118
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2649) 2649
German (86) 86
French (74) 74
Spanish (35) 35
Russian (25) 25
Japanese (24) 24
Hungarian (7) 7
Italian (6) 6
Czech (4) 4
Polish (4) 4
Arabic (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 01/2010, Volume 115, Issue 1, pp. 15 - 20
Journal Article
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1646, pp. 217 - 225
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 02/2013, Volume 34, Issue 7, pp. 489 - 500
Novel oral anticoagulants that directly inhibit thrombin (dabigatran) or factor Xa (rivaroxaban, apixaban) are currently available for prevention of venous... 
Novel oral anticoagulants | Bleeding | Management | RECOMBINANT FACTOR-VIIA | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | RANDOMIZED EVALUATION | INTRACRANIAL HEMORRHAGE | ACTIVATED FACTOR-VII | FACTOR-XA INHIBITOR | DABIGATRAN ETEXILATE | VENOUS THROMBOEMBOLISM | PROTHROMBIN COMPLEX CONCENTRATE | NONVALVULAR ATRIAL-FIBRILLATION | Plasma | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Antithrombins - administration & dosage | Hemorrhage - prevention & control | Thiophenes - administration & dosage | Dabigatran | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | beta-Alanine - pharmacology | Renal Insufficiency - complications | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Morpholines - adverse effects | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Acute Disease | beta-Alanine - adverse effects | Administration, Oral | Morpholines - administration & dosage | Risk Factors | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - adverse effects | Pyrazoles - administration & dosage | Anticoagulants - pharmacology | Antithrombins - adverse effects | Blood Coagulation Tests | Benzimidazoles - pharmacology | Aged | Hemostatics - therapeutic use | Pyridones - adverse effects | Pyridones - pharmacology | Renal Dialysis
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2013, Volume 88, Issue 5, pp. 495 - 511
Journal Article